about
Telerehab III: a multi-center randomized, controlled trial investigating the long-term effectiveness of a comprehensive cardiac telerehabilitation program--rationale and study design.Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial.A review of telerehabilitation for cardiac patients.eEduHeart I: A Multicenter, Randomized, Controlled Trial Investigating the Effectiveness of a Cardiac Web-Based eLearning Platform - Rationale and Study Design.The future of telerehabilitation: empowerment of patients versus long distance supervision.Compromised Cardiopulmonary Exercise Capacity in Patients Early After Endoscopic Atraumatic Coronary Artery Bypass Graft: Implications for Rehabilitation.Economic and social impact of increased cardiac rehabilitation uptake and cardiac telerehabilitation in Belgium - a cost-benefit analysis.Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: A cost-effectiveness analysis.Increasing the medium-term clinical benefits of hospital-based cardiac rehabilitation by physical activity telemonitoring in coronary artery disease patients.Septo-optic dysplasia: illustration of a case.Cardiac telerehabilitation: A novel cost-efficient care delivery strategy that can induce long-term health benefits.Challenges in secondary prevention after acute myocardial infarction: A call for action.Challenges in secondary prevention after acute myocardial infarction: A call for action.FIT@Home editorial: Supporting a new era of cardiac rehabilitation at home?Who needs secondary prevention?Long-term impact of a six-month telemedical care programme on mortality, heart failure readmissions and healthcare costs in patients with chronic heart failureHow to reliably diagnose arterial hypertension: lessons from 24 h blood pressure monitoringThe role of cardiac rehabilitation in vocational reintegration Belgian working group of cardiovascular prevention and rehabilitation position paper
P50
Q35610121-4C1F5034-778D-433E-91BA-AC209C33353FQ35925690-D8E171C6-0F3C-4AC7-B1F1-666CEB7A3E06Q38283147-D8409C8C-E580-47E4-9B31-CCABA17F8C4BQ39362392-88F3AA75-870F-49D5-921E-DC25B74C6CF5Q39408997-DC42F2A0-6A00-453C-B457-C262398B0B0DQ39769415-960E0804-543D-420D-8513-960DC36E109DQ40097446-75FEE7DD-3728-4D8E-BDD6-FF78100F5B33Q40306699-67CB2B18-BD83-4F02-B23E-F3CAA9623B32Q44739720-18D3E86C-E87C-47B3-AB7E-6145BA694D3AQ45999164-4EE5E86E-F899-4E22-B18F-F26CE705DE55Q47941657-6FDC3C6E-8092-457E-8046-E9D0DA16D168Q52838141-929D1060-B498-4069-AF7F-33E790E4D95AQ52847951-03E3BAB4-D6EE-4AA8-9AE3-710F0A2EEB69Q53224035-C09FC7BE-711A-45FA-8879-9B8582855822Q54270585-2151DA14-1824-47EF-806A-AF3EA2DC042AQ88617094-58CB71D9-1518-4CFA-977C-3269C5F5F288Q90946336-7BE08915-01FF-4112-BB99-B1CA2765ED5DQ92505479-7306E1B1-32AA-4CA4-82A1-5984E7B2AFE8
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ines Frederix
@ast
Ines Frederix
@en
Ines Frederix
@es
Ines Frederix
@nl
type
label
Ines Frederix
@ast
Ines Frederix
@en
Ines Frederix
@es
Ines Frederix
@nl
prefLabel
Ines Frederix
@ast
Ines Frederix
@en
Ines Frederix
@es
Ines Frederix
@nl
P106
P21
P31
P496
0000-0001-8636-5972